ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 99 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $245,000 | +5.2% | 43,481 | +2.4% | 0.18% | +136.0% |
| Q2 2016 | $233,000 | -24.4% | 42,481 | +2.4% | 0.08% | -25.0% |
| Q1 2016 | $308,000 | +25.2% | 41,481 | +39.8% | 0.10% | +37.0% |
| Q4 2015 | $246,000 | -7.9% | 29,662 | 0.0% | 0.07% | -11.0% |
| Q3 2015 | $267,000 | -22.4% | 29,662 | +3.5% | 0.08% | -14.6% |
| Q2 2015 | $344,000 | -9.9% | 28,662 | -19.3% | 0.10% | -7.7% |
| Q1 2015 | $382,000 | +112.2% | 35,500 | 0.0% | 0.10% | +116.7% |
| Q4 2014 | $180,000 | +104.5% | 35,500 | +6.0% | 0.05% | +100.0% |
| Q3 2014 | $88,000 | -32.8% | 33,500 | +3.1% | 0.02% | -33.3% |
| Q2 2014 | $131,000 | -6.4% | 32,500 | +6.6% | 0.04% | -7.7% |
| Q1 2014 | $140,000 | +6.1% | 30,500 | 0.0% | 0.04% | 0.0% |
| Q4 2013 | $132,000 | +123.7% | 30,500 | +103.3% | 0.04% | +95.0% |
| Q3 2013 | $59,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |